n-formylmethionine leucyl-phenylalanine has been researched along with Diseases of Immune System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlain, JM; Daiss, JL; Dewhurst, S; Gelbard, HA; Goodfellow, V; Kim, M; Lebron, L; Polesskaya, O; Wong, C | 1 |
| Brown, CC; Gallin, JI | 1 |
1 review(s) available for n-formylmethionine leucyl-phenylalanine and Diseases of Immune System
| Article | Year |
|---|---|
Chemotactic disorders.
Topics: Chemotactic Factors; Chemotaxis; Humans; Immune System Diseases; Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Neoplasms; Phagocyte Bactericidal Dysfunction | 1988 |
1 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Diseases of Immune System
| Article | Year |
|---|---|
MLK3 regulates fMLP-stimulated neutrophil motility.
Topics: Animals; Cell Migration Inhibition; Cell Survival; Cells, Cultured; Chemotactic Factors; Immune System Diseases; Leukocyte Disorders; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase Kinase Kinase 11; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Protein Kinase Inhibitors; Pyridines; Pyrroles | 2014 |